Literature DB >> 2658580

Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome.

R L Berkelman1, W L Heyward, J K Stehr-Green, J W Curran.   

Abstract

As of December 31, 1988, 82,764 cases of acquired immunodeficiency syndrome (AIDS) and more than 46,000 AIDS-related deaths had been reported in the United States. In 1987, AIDS deaths accounted for 9% of the total mortality among men 25 to 34 years of age. Projections suggest that the impact of human immunodeficiency virus (HIV) infection on morbidity and mortality in young adults and children will continue to increase, with an estimated 50,000 cases projected to be diagnosed in 1989. The mean latency period between infection and diagnosis of AIDS is estimated to be more than seven years, and 78% to 100% of persons infected with HIV are predicted to develop AIDS within 15 years of onset of infection. Rates of seroconversions have been decreasing since 1984 among cohorts of homosexual HIV-seronegative men, and the proportion of AIDS cases among homosexual men is decreasing. In contrast, the proportion of AIDS cases attributed to intravenous drug use is increasing, with 33% of AIDS cases reported in 1988 occurring among intravenous drug users, their sex partners, or children of women who are intravenous drug users or sex partners of intravenous drug users. Worldwide, the differences in the epidemiology of HIV infection and AIDS are primarily due to differences in the proportions of the modes of transmission and in the time in which HIV infection was introduced.

Entities:  

Mesh:

Year:  1989        PMID: 2658580     DOI: 10.1016/0002-9343(89)90470-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Methods of surveillance for HIV infection at U.S. sentinel hospitals.

Authors:  M E St Louis; N Olivo; S Critchley; K J Rauch; C R White; V P Munn; T J Dondero
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

Review 2.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

3.  Learning to recognize scarring among intravenous drug users: a tool for HIV risk reduction.

Authors:  H W Horowitz
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

4.  HIV: evolution of a pandemic.

Authors:  C Hankins
Journal:  CMAJ       Date:  1995-12-01       Impact factor: 8.262

5.  Blinded comparison of a direct immunofluorescent monoclonal antibody staining method and a Giemsa staining method for identification of Pneumocystis carinii in induced sputum and bronchoalveolar lavage specimens of patients infected with human immunodeficiency virus.

Authors:  J S Wolfson; M A Waldron; L S Sierra
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.

Authors:  P Kumar; H X Hui; J C Kappes; B S Haggarty; J A Hoxie; S K Arya; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Risk for AIDS in multiethnic neighborhoods in San Francisco, California. The population-based AMEN Study.

Authors:  M T Fullilove; J Wiley; R E Fullilove; E Golden; J Catania; J Peterson; K Garrett; D Siegel; B Marin; S Kegeles
Journal:  West J Med       Date:  1992-07

8.  HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.

Authors:  H A Siegal; R G Carlson; R Falck; L Li; M A Forney; R C Rapp; K Baumgartner; W Myers; M Nelson
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

9.  Substance abuse and AIDS: a faculty development program for primary care providers.

Authors:  P G O'Connor; J Bigby; D Gallagher
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

10.  Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map.

Authors:  Gaelen P Adam; Mengyang Di; Susan Cu-Uvin; Christopher Halladay; Bryant T Smith; Suchitra Iyer; Thomas A Trikalinos
Journal:  Syst Rev       Date:  2018-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.